Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.97 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 45.02.
Market Cap
8.97T
Revenue
4.59T
Profits
199.33B
PE Ratio
45.02
Profit Margin
4.34%
Dividend Yield
0.40%
1056 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.08T | 7.13% | 7,725,848 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 613.02B | 3.99% | 16,316,770 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 447.62B | 4.20% | 52,635,078 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 388.59B | 2.97% | 10,588,248 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 317.77B | 2.56% | 18,891,534 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 293.49B | 1.47% | 3,235,391 | 60.44B |
| 7 | NVS | Novartis AG | 286.02B | 0.19% | 3,831,260 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 214.87B | 0.90% | 20,136,350 | 50.57B |
| 9 | AMGN | Amgen Inc. | 193.39B | 1.56% | 3,610,562 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 190.65B | 1.44% | 4,570,072 | 45.20B |
| 11 | ABT | Abbott Laboratories | 163.94B | 0.94% | 16,465,118 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 158.77B | 3.26% | 19,908,542 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 143.33B | 1.25% | 3,413,593 | 10.58B |
| 14 | DHR | Danaher Corporation | 138.86B | 1.75% | 6,090,455 | 24.78B |
| 15 | PFE | Pfizer Inc. | 138.44B | 2.62% | 59,958,944 | 63.32B |
| 16 | CVS | CVS Health Corporation | 133.13B | -0.31% | 9,690,891 | 405.62B |
| 17 | SYK | Stryker Corporation | 127.55B | 5.25% | 5,507,882 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 124.70B | 2.32% | 8,693,048 | 12.22B |
| 19 | BMY | Bristol-Myers Squibb Company | 117.46B | 3.85% | 24,000,913 | 48.48B |
| 20 | GSK | GSK plc | 104.43B | 1.18% | 4,205,019 | 43.29B |
| 21 | MDT | Medtronic plc | 103.66B | 1.48% | 12,401,090 | 36.36B |
| 22 | SNY | Sanofi | 102.76B | 2.75% | 6,762,101 | 54.60B |
| 23 | MCK | McKesson Corporation | 89.39B | -0.04% | 1,736,310 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 86.89B | 1.22% | 2,208,311 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 85.82B | 2.03% | 2,913,683 | 200.42B |
| 26 | CI | The Cigna Group | 74.81B | 0.33% | 3,279,723 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 65.74B | 0.07% | 30,011,483 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 64.39B | 2.06% | 1,213,634 | 14.92B |
| 29 | CAH | Cardinal Health, Inc. | 55.72B | 1.35% | 3,633,366 | 250.74B |
| 30 | COR | Cencora, Inc. | 55.67B | -0.29% | 2,925,870 | 328.68B |
| 31 | ARGX | argenx SE | 55.63B | -0.17% | 400,919 | 4.74B |
| 32 | EW | Edwards Lifesciences Corporation | 52.27B | 1.18% | 14,420,825 | 6.30B |
| 33 | MDLN | Medline Inc. | 51.06B | 2.91% | 11,276,957 | 29.14B |
| 34 | TAK | Takeda Pharmaceutical Company Limited | 50.58B | 1.66% | 2,766,432 | 28.34B |
| 35 | HUM | Humana Inc. | 46.08B | 2.32% | 1,704,877 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.50B | -0.62% | 1,314,757 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 42.96B | 3.00% | 12,180,749 | 22.23B |
| 38 | HLN | Haleon plc | 40.58B | -0.32% | 12,468,972 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.90B | -0.61% | 1,490,611 | 4.29B |
| 40 | RVMD | Revolution Medicines, Inc. | 38.71B | 2.19% | 9,544,061 | - |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 38.67B | -1.22% | 4,703,604 | 17.35B |
| 42 | A | Agilent Technologies, Inc. | 38.41B | 0.37% | 3,133,368 | 7.23B |
| 43 | NTRA | Natera, Inc. | 37.51B | 0.45% | 3,411,941 | 2.50B |
| 44 | WAT | Waters Corporation | 36.76B | -0.66% | 2,032,519 | 3.77B |
| 45 | ALC | Alcon Inc. | 33.31B | -0.48% | 1,485,012 | 10.63B |
| 46 | CNC | Centene Corporation | 32.46B | 1.48% | 5,803,720 | 178.33B |
| 47 | RPRX | Royalty Pharma plc | 32.38B | 2.82% | 6,979,838 | 2.44B |
| 48 | IQV | IQVIA Holdings Inc. | 31.90B | 2.53% | 1,775,153 | 16.63B |
| 49 | ZTS | Zoetis Inc. | 31.90B | -2.22% | 15,723,340 | 9.53B |
| 50 | BIIB | Biogen Inc. | 31.89B | 6.97% | 2,374,525 | 9.94B |
| 51 | ONC | BeOne Medicines AG | 31.12B | 1.65% | 336,792 | 5.70B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.91B | 1.26% | 5,191,634 | 20.98B |
| 53 | RMD | ResMed Inc. | 28.93B | 0.85% | 2,102,372 | 5.54B |
| 54 | VEEV | Veeva Systems Inc. | 27.84B | 8.40% | 5,660,089 | 3.32B |
| 55 | DXCM | DexCom, Inc. | 27.07B | 2.17% | 6,872,597 | 4.82B |
| 56 | ILMN | Illumina, Inc. | 26.71B | -0.62% | 2,196,287 | 4.39B |
| 57 | MRNA | Moderna, Inc. | 26.69B | 12.59% | 14,456,655 | 2.23B |
| 58 | PHG | Koninklijke Philips N.V. | 25.94B | -0.70% | 908,924 | 20.34B |
| 59 | MTD | Mettler-Toledo International Inc. | 25.54B | 1.64% | 381,159 | 4.09B |
| 60 | WST | West Pharmaceutical Services, Inc. | 24.79B | 1.24% | 1,254,978 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 24.51B | 0.15% | 12,406,498 | 8.26M |
| 62 | DGX | Quest Diagnostics Incorporated | 23.23B | 1.76% | 1,349,746 | 11.28B |
| 63 | BNTX | BioNTech SE | 23.07B | 1.36% | 873,630 | 3.23B |
| 64 | UTHR | United Therapeutics Corporation | 23.03B | -0.13% | 1,022,245 | 3.17B |
| 65 | INCY | Incyte Corporation | 22.73B | 5.78% | 3,795,267 | 5.36B |
| 66 | INSM | Insmed Incorporated | 22.41B | -1.04% | 6,259,750 | 819.56M |
| 67 | LH | Labcorp Holdings Inc. | 22.26B | 1.93% | 1,034,023 | 14.14B |
| 68 | STE | STERIS plc | 21.02B | 2.41% | 1,232,345 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 19.79B | 4.39% | 18,771,298 | 1.08B |
| 70 | VTRS | Viatris Inc. | 19.02B | 1.62% | 12,849,203 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 18.01B | 2.35% | 2,281,799 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.94B | 2.64% | 1,953,261 | 3.10B |
| 73 | THC | Tenet Healthcare Corporation | 16.28B | 2.75% | 1,569,330 | 21.46B |
| 74 | ASND | Ascendis Pharma A/S | 16.20B | -0.32% | 4,450,794 | 998.25M |
| 75 | GMAB | Genmab A/S | 15.94B | -0.08% | 1,778,430 | 3.90B |
| 76 | MEDP | Medpace Holdings, Inc. | 15.05B | 1.37% | 399,921 | 2.68B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 14.43B | 1.69% | 845,914 | 4.44B |
| 78 | BTSG | BrightSpring Health Services, Inc. | 14.37B | -1.03% | 10,450,197 | 13.65B |
| 79 | DVA | DaVita Inc. | 13.93B | 1.72% | 1,669,491 | 13.84B |
| 80 | COO | The Cooper Companies, Inc. | 13.85B | 0.54% | 3,489,853 | 4.23B |
| 81 | SOLV | Solventum Corporation | 13.77B | 2.07% | 2,922,362 | 8.26B |
| 82 | EXEL | Exelixis, Inc. | 13.77B | 2.89% | 6,931,469 | 2.38B |
| 83 | BBIO | BridgeBio Pharma, Inc. | 13.76B | 0.79% | 27,055,505 | 579.96M |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 13.42B | 3.63% | 3,828,331 | 1.06B |
| 85 | ICLR | ICON Public Limited Company | 13.01B | 5.53% | 1,443,150 | 8.27B |
| 86 | ALGN | Align Technology, Inc. | 12.78B | 1.55% | 1,668,669 | 4.10B |
| 87 | SNN | Smith & Nephew plc | 12.77B | -0.60% | 1,717,803 | 6.16B |
| 88 | RVTY | Revvity, Inc. | 12.61B | -0.45% | 3,674,634 | 2.90B |
| 89 | FMS | Fresenius Medical Care AG | 12.52B | -0.04% | 398,333 | 22.32B |
| 90 | PEN | Penumbra, Inc. | 12.45B | -0.24% | 546,357 | 1.45B |
| 91 | AXSM | Axsome Therapeutics, Inc. | 12.44B | 1.83% | 7,350,039 | 708.24M |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.27B | 0.82% | 6,057,313 | 4.89B |
| 93 | MOH | Molina Healthcare, Inc. | 11.97B | 6.34% | 2,622,708 | 43.10B |
| 94 | RDY | Dr. Reddy's Laboratories Limited | 11.91B | 0.85% | 3,693,979 | 3.58B |
| 95 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.82B | -0.22% | 2,500,272 | 1.13B |
| 96 | GMED | Globus Medical, Inc. | 11.71B | 1.89% | 2,490,998 | 3.10B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.40B | 2.88% | 3,709,816 | 3.24B |
| 98 | BAX | Baxter International Inc. | 11.38B | 2.27% | 10,260,239 | 11.32B |
| 99 | CYTK | Cytokinetics, Incorporated | 11.16B | 1.72% | 7,164,201 | 105.82M |
| 100 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.11B | -0.48% | 18,919,782 | 622.01M |
| 101 | TECH | Bio-Techne Corporation | 11.06B | 0.42% | 12,259,475 | 1.21B |
| 102 | KRYS | Krystal Biotech, Inc. | 10.97B | 3.42% | 1,307,875 | 417.30M |
| 103 | PODD | Insulet Corporation | 10.96B | 2.88% | 2,779,107 | 2.90B |
| 104 | SMMT | Summit Therapeutics Inc. | 10.87B | -1.20% | 4,183,357 | - |
| 105 | CRL | Charles River Laboratories International, Inc. | 10.39B | 1.43% | 1,445,803 | 4.03B |
| 106 | TEM | Tempus AI, Inc. | 10.08B | 2.31% | 9,674,513 | 1.36B |
| 107 | EHC | Encompass Health Corporation | 10.05B | 1.61% | 2,459,163 | 6.07B |
| 108 | APGE | Apogee Therapeutics, Inc. | 9.93B | -0.10% | 5,109,503 | - |
| 109 | NUVL | Nuvalent, Inc. | 9.76B | -0.01% | 2,989,430 | - |
| 110 | HSIC | Henry Schein, Inc. | 9.68B | 1.51% | 2,350,416 | 13.38B |
| 111 | ENSG | The Ensign Group, Inc. | 9.45B | -1.62% | 8,087,959 | 5.27B |
| 112 | CORT | Corcept Therapeutics Incorporated | 9.37B | 3.03% | 1,591,004 | 769.10M |
| 113 | BRKR | Bruker Corporation | 9.27B | 0.03% | 2,322,174 | 3.46B |
| 114 | ALKS | Alkermes plc | 9.18B | 4.26% | 7,563,601 | 1.56B |
| 115 | PRAX | Praxis Precision Medicines, Inc. | 9.14B | -0.02% | 2,060,214 | 7.46M |
| 116 | IBRX | ImmunityBio, Inc. | 9.12B | 11.81% | 41,198,290 | 140.98M |
| 117 | OSCR | Oscar Health, Inc. | 8.97B | 3.91% | 15,475,680 | 13.30B |
| 118 | KYMR | Kymera Therapeutics, Inc. | 8.89B | -7.16% | 4,264,235 | 51.48M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 8.89B | 3.19% | 2,872,450 | 1.51B |
| 120 | UHS | Universal Health Services, Inc. | 8.82B | 0.85% | 918,524 | 17.76B |
| 121 | GKOS | Glaukos Corporation | 8.48B | 1.30% | 1,989,559 | 551.35M |
| 122 | RGEN | Repligen Corporation | 8.29B | 1.23% | 1,966,214 | 763.34M |
| 123 | PCVX | Vaxcyte, Inc. | 8.16B | 5.29% | 8,654,450 | - |
| 124 | QGEN | Qiagen N.V. | 8.15B | 1.21% | 3,629,145 | 2.10B |
| 125 | BIO | Bio-Rad Laboratories, Inc. | 8.05B | 0.84% | 481,974 | 2.59B |
| 126 | ATR | AptarGroup, Inc. | 8.04B | -0.36% | 727,449 | 3.87B |
| 127 | IMVT | Immunovant, Inc. | 7.98B | 1.60% | 3,718,041 | - |
| 128 | TGTX | TG Therapeutics, Inc. | 7.91B | 4.10% | 6,852,292 | 700.35M |
| 129 | HIMS | Hims & Hers Health, Inc. | 7.86B | 3.76% | 21,434,512 | 2.37B |
| 130 | PTGX | Protagonist Therapeutics, Inc. | 7.84B | -0.61% | 2,593,942 | 74.06M |
| 131 | ABVX | ABIVAX Société Anonyme | 7.68B | 5.55% | 1,666,908 | 5.67M |
| 132 | SYRE | Spyre Therapeutics, Inc. | 7.63B | -0.88% | 4,441,241 | - |
| 133 | MIRM | Mirum Pharmaceuticals, Inc. | 7.55B | 5.53% | 3,372,779 | 569.61M |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.53B | 1.46% | 2,664,342 | 217.17M |
| 135 | HQY | HealthEquity, Inc. | 7.40B | 6.03% | 2,697,206 | 1.34B |
| 136 | LNTH | Lantheus Holdings, Inc. | 7.15B | 0.72% | 2,499,897 | 1.55B |
| 137 | AVTR | Avantor, Inc. | 7.02B | 1.98% | 10,622,427 | 6.55B |
| 138 | PTCT | PTC Therapeutics, Inc. | 7.00B | -0.09% | 3,903,105 | 827.11M |
| 139 | LQDA | Liquidia Corporation | 6.95B | 1.63% | 3,812,850 | 288.07M |
| 140 | PACS | PACS Group, Inc. | 6.63B | 2.97% | 1,918,812 | 5.43B |
| 141 | SRRK | Scholar Rock Holding Corporation | 6.56B | 1.80% | 7,570,575 | - |
| 142 | COGT | Cogent Biosciences, Inc. | 6.51B | 0.24% | 9,948,153 | - |
| 143 | CGON | CG Oncology, Inc. | 6.35B | -1.21% | 4,852,037 | 5.07M |
| 144 | GRFS | Grifols, S.A. | 6.34B | 0.27% | 415,136 | 8.58B |
| 145 | TWST | Twist Bioscience Corporation | 6.22B | 3.30% | 4,275,455 | 409.48M |
| 146 | CHE | Chemed Corporation | 6.12B | 2.24% | 230,728 | 2.54B |
| 147 | HNGE | Hinge Health, Inc. | 6.11B | 5.10% | 8,946,939 | 646.34M |
| 148 | LGND | Ligand Pharmaceuticals Incorporated | 6.08B | 2.59% | 1,250,981 | 274.48M |
| 149 | DFTX | Definium Therapeutics, Inc. | 5.97B | 0.36% | 12,213,459 | - |
| 150 | BLTE | Belite Bio, Inc | 5.85B | -0.73% | 255,725 | - |
| 151 | BLCO | Bausch + Lomb Corporation | 5.82B | 2.58% | 414,529 | 5.21B |
| 152 | XENE | Xenon Pharmaceuticals Inc. | 5.77B | 5.21% | 8,840,002 | 7.50M |
| 153 | TFX | Teleflex Incorporated | 5.75B | 1.62% | 602,444 | 2.13B |
| 154 | LEGN | Legend Biotech Corporation | 5.55B | 0.91% | 2,829,042 | 1.14B |
| 155 | AMRX | Amneal Pharmaceuticals, Inc. | 5.50B | -0.52% | 8,248,921 | 3.05B |
| 156 | TVTX | Travere Therapeutics, Inc. | 5.47B | -0.30% | 4,896,262 | 536.20M |
| 157 | ORKA | Oruka Therapeutics, Inc. | 5.46B | 4.58% | 4,733,610 | - |
| 158 | BLLN | BillionToOne, Inc. | 5.44B | 5.28% | 962,629 | 354.54M |
| 159 | MANE | Veradermics, Incorporated | 5.30B | 6.30% | 4,047,393 | - |
| 160 | CRSP | CRISPR Therapeutics AG | 5.30B | 1.74% | 3,392,916 | 4.10M |
| 161 | CAI | Caris Life Sciences, Inc. | 5.23B | -1.07% | 7,281,076 | 907.29M |
| 162 | DNTH | Dianthus Therapeutics, Inc. | 5.21B | 4.13% | 5,658,787 | 1.34M |
| 163 | INDV | Indivior Pharmaceuticals, Inc. | 5.10B | 1.31% | 5,608,910 | 1.29B |
| 164 | ERAS | Erasca, Inc. | 4.98B | 7.09% | 18,335,394 | - |
| 165 | SHC | Sotera Health Company | 4.96B | 1.64% | 3,945,431 | 1.19B |
| 166 | CELC | Celcuity Inc. | 4.87B | 4.19% | 2,565,087 | - |
| 167 | STVN | Stevanato Group S.p.A. | 4.87B | -2.99% | 327,959 | 1.39B |
| 168 | VCYT | Veracyte, Inc. | 4.83B | 3.31% | 3,333,219 | 541.74M |
| 169 | ALHC | Alignment Healthcare, Inc. | 4.79B | 2.11% | 6,558,867 | 4.26B |
| 170 | RDNT | RadNet, Inc. | 4.78B | 1.22% | 3,019,355 | 2.14B |
| 171 | TXG | 10x Genomics, Inc. | 4.67B | 2.85% | 9,267,688 | 638.78M |
| 172 | LIVN | LivaNova PLC | 4.58B | 2.94% | 2,003,412 | 1.43B |
| 173 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.55B | 4.06% | 6,756,126 | 754.05M |
| 174 | TNGX | Tango Therapeutics, Inc. | 4.55B | 4.41% | 15,371,098 | 56.99M |
| 175 | EWTX | Edgewise Therapeutics, Inc. | 4.46B | -0.55% | 2,810,757 | - |
| 176 | VKTX | Viking Therapeutics, Inc. | 4.42B | 2.84% | 3,782,562 | - |
| 177 | NVST | Envista Holdings Corporation | 4.39B | 1.20% | 3,296,776 | 2.81B |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 4.34B | 6.75% | 7,370,513 | 1.10B |
| 179 | MMSI | Merit Medical Systems, Inc. | 4.28B | 1.27% | 3,013,316 | 1.54B |
| 180 | DNLI | Denali Therapeutics Inc. | 4.06B | 3.40% | 6,526,874 | - |
| 181 | RLAY | Relay Therapeutics, Inc. | 4.04B | 4.09% | 12,573,934 | 10.68M |
| 182 | MMED | MiniMed Group, Inc. | 4.00B | 0.14% | 6,306,880 | 3.10B |
| 183 | LFST | LifeStance Health Group, Inc. | 3.99B | 4.05% | 14,419,399 | 1.49B |
| 184 | IRTC | iRhythm Holdings, Inc. | 3.91B | 2.50% | 1,277,374 | 787.85M |
| 185 | RCUS | Arcus Biosciences, Inc. | 3.90B | 2.48% | 4,352,592 | 236.00M |
| 186 | NAMS | NewAmsterdam Pharma Company N.V. | 3.89B | 4.76% | 1,580,202 | 22.57M |
| 187 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.87B | 4.89% | 5,046,397 | 18.07M |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 3.86B | 1.93% | 2,994,693 | 2.23B |
| 189 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.86B | 0.25% | 4,067,136 | 596.96M |
| 190 | DOCS | Doximity, Inc. | 3.82B | 5.19% | 9,847,737 | 644.86M |
| 191 | WAY | Waystar Holding Corp. | 3.82B | 4.96% | 7,400,371 | 1.16B |
| 192 | BKD | Brookdale Senior Living Inc. | 3.75B | 1.95% | 17,182,016 | 3.00B |
| 193 | ICUI | ICU Medical, Inc. | 3.71B | -0.38% | 902,540 | 2.16B |
| 194 | PBLS | Parabilis Medicines, Inc. | 3.67B | 9.26% | 581,320 | - |
| 195 | TLX | Telix Pharmaceuticals Limited | 3.59B | -1.84% | 125,480 | 803.79M |
| 196 | WRBY | Warby Parker Inc. | 3.59B | 6.33% | 5,656,551 | 890.57M |
| 197 | OGN | Organon & Co. | 3.55B | 0.22% | 2,888,686 | 6.16B |
| 198 | GPCR | Structure Therapeutics Inc. | 3.53B | 3.03% | 885,732 | - |
| 199 | HAE | Haemonetics Corporation | 3.51B | -0.43% | 1,608,297 | 1.33B |
| 200 | ELVN | Enliven Therapeutics, Inc. | 3.50B | 1.95% | 6,636,521 | - |
| 201 | IDYA | IDEAYA Biosciences, Inc. | 3.49B | 1.24% | 3,681,145 | 225.27M |
| 202 | BEAM | Beam Therapeutics Inc. | 3.46B | 2.59% | 4,788,375 | 164.01M |
| 203 | DYN | Dyne Therapeutics, Inc. | 3.46B | 1.60% | 5,436,287 | - |
| 204 | OPCH | Option Care Health, Inc. | 3.43B | 1.58% | 7,762,636 | 5.67B |
| 205 | ARQT | Arcutis Biotherapeutics, Inc. | 3.38B | 1.16% | 3,711,680 | 415.62M |
| 206 | ALMS | Alumis Inc. | 3.37B | 5.47% | 6,164,557 | 8.40M |
| 207 | ADPT | Adaptive Biotechnologies Corporation | 3.35B | 3.51% | 6,474,447 | 295.41M |
| 208 | QURE | uniQure N.V. | 3.27B | -3.24% | 3,155,990 | 18.09M |
| 209 | NHC | National HealthCare Corporation | 3.23B | 2.49% | 503,970 | 1.53B |
| 210 | PRVA | Privia Health Group, Inc. | 3.22B | 4.24% | 4,444,673 | 2.25B |
| 211 | RGC | Regencell Bioscience Holdings Limited | 3.21B | -13.48% | 497,538 | - |
| 212 | ITGR | Integer Holdings Corporation | 3.19B | 0.83% | 1,530,225 | 1.86B |
| 213 | HTFL | HeartFlow, Inc. | 3.07B | 1.92% | 12,523,687 | 191.42M |
| 214 | VERA | Vera Therapeutics, Inc. | 3.05B | 4.84% | 4,151,310 | - |
| 215 | RARE | Ultragenyx Pharmaceutical Inc. | 3.02B | 5.20% | 17,178,497 | 670.00M |
| 216 | IRON | Disc Medicine, Inc. | 2.86B | 6.58% | 1,904,001 | - |
| 217 | CLOV | Clover Health Investments, Corp. | 2.85B | 3.84% | 15,084,537 | 2.21B |
| 218 | GRAL | GRAIL, Inc. | 2.83B | -0.98% | 1,726,055 | 156.12M |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.77B | 3.43% | 4,785,830 | 865.00K |
| 220 | SUPN | Supernus Pharmaceuticals, Inc. | 2.72B | 4.67% | 3,338,839 | 776.83M |
| 221 | TARS | Tarsus Pharmaceuticals, Inc. | 2.71B | -2.21% | 2,025,059 | 535.08M |
| 222 | KLRA | Kailera Therapeutics, Inc. | 2.70B | 0.82% | 7,448,117 | - |
| 223 | GRDN | Guardian Pharmacy Services, Inc. | 2.68B | 8.82% | 998,658 | 1.46B |
| 224 | ESTA | Establishment Labs Holdings Inc. | 2.60B | -0.77% | 5,278,872 | 229.58M |
| 225 | TRVI | Trevi Therapeutics, Inc. | 2.58B | 0.83% | 6,901,834 | - |
| 226 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.53B | 0.40% | 10,986,514 | 885.72M |
| 227 | ACHC | Acadia Healthcare Company, Inc. | 2.52B | 4.50% | 15,689,070 | 3.37B |
| 228 | MBX | MBX Biosciences, Inc. | 2.49B | 3.85% | 2,888,471 | - |
| 229 | AXGN | Axogen, Inc. | 2.39B | 0.99% | 3,280,197 | 238.11M |
| 230 | BHVN | Biohaven Ltd. | 2.38B | 3.19% | 9,513,018 | - |
| 231 | PHVS | Pharvaris N.V. | 2.38B | 2.13% | 519,304 | - |
| 232 | NRIX | Nurix Therapeutics, Inc. | 2.37B | 1.96% | 6,491,365 | 71.78M |
| 233 | TMDX | TransMedics Group, Inc. | 2.37B | -11.97% | 3,704,074 | 635.89M |
| 234 | VCEL | Vericel Corporation | 2.36B | 7.76% | 2,336,228 | 292.09M |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.35B | 1.29% | 5,199,187 | - |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.34B | 4.73% | 1,952,372 | 1.09B |
| 237 | NTLA | Intellia Therapeutics, Inc. | 2.33B | 4.05% | 9,823,555 | 66.09M |
| 238 | BFLY | Butterfly Network, Inc. | 2.33B | 10.85% | 17,053,039 | 102.92M |
| 239 | SLS | SELLAS Life Sciences Group, Inc. | 2.30B | 17.66% | 21,005,639 | - |
| 240 | IMNM | Immunome, Inc. | 2.26B | 2.89% | 4,334,667 | 4.02M |
| 241 | AGIO | Agios Pharmaceuticals, Inc. | 2.25B | 4.70% | 3,836,443 | 66.05M |
| 242 | ABCL | AbCellera Biologics Inc. | 2.25B | 10.81% | 15,607,753 | 79.21M |
| 243 | KOD | Kodiak Sciences Inc. | 2.24B | 5.43% | 2,591,123 | - |
| 244 | PGNY | Progyny, Inc. | 2.23B | 4.13% | 1,597,353 | 1.29B |
| 245 | AUPH | Aurinia Pharmaceuticals Inc. | 2.22B | -1.82% | 4,497,561 | 298.30M |
| 246 | ASTH | Astrana Health, Inc. | 2.21B | 2.32% | 1,964,618 | 3.53B |
| 247 | XRAY | DENTSPLY SIRONA Inc. | 2.21B | 2.13% | 32,233,980 | 3.68B |
| 248 | LMAT | LeMaitre Vascular, Inc. | 2.19B | 1.84% | 856,737 | 256.28M |
| 249 | OCUL | Ocular Therapeutix, Inc. | 2.15B | 0.82% | 8,123,877 | 52.04M |
| 250 | NKTR | Nektar Therapeutics | 2.15B | 2.61% | 6,152,225 | 55.63M |
| 251 | PVLA | Palvella Therapeutics, Inc. | 2.13B | 8.82% | 1,173,517 | - |
| 252 | GENB | Generate Biomedicines, Inc. | 2.11B | 0.30% | 4,095,288 | 30.30M |
| 253 | KARD | Kardigan, Inc. | 2.11B | 4.52% | 852,374 | - |
| 254 | PGEN | Precigen, Inc. | 2.09B | 6.16% | 11,313,032 | 31.60M |
| 255 | NEOG | Neogen Corporation | 2.09B | 0.74% | 5,339,905 | 870.56M |
| 256 | WGS | GeneDx Holdings Corp. | 2.07B | 1.67% | 1,379,552 | 442.68M |
| 257 | HRMY | Harmony Biosciences Holdings, Inc. | 2.05B | 3.93% | 1,766,109 | 899.11M |
| 258 | SGRY | Surgery Partners, Inc. | 2.05B | 2.33% | 2,948,406 | 3.34B |
| 259 | SEM | Select Medical Holdings Corporation | 2.05B | -0.30% | 12,955,435 | 5.52B |
| 260 | ADMA | ADMA Biologics, Inc. | 2.03B | 0.34% | 5,934,468 | 509.86M |
| 261 | TSHA | Taysha Gene Therapies, Inc. | 2.03B | 2.09% | 10,818,447 | 7.47M |
| 262 | ZLAB | Zai Lab Limited | 2.02B | -2.81% | 1,855,223 | 453.28M |
| 263 | UFPT | UFP Technologies, Inc. | 2.01B | 2.80% | 355,562 | 608.85M |
| 264 | CMPS | COMPASS Pathways plc | 2.00B | 9.13% | 5,486,748 | - |
| 265 | STOK | Stoke Therapeutics, Inc. | 1.99B | 5.26% | 3,258,298 | 32.08M |
| 266 | AGL | agilon health, inc. | 1.99B | 11.19% | 637,724 | 5.82B |
| 267 | MD | Pediatrix Medical Group, Inc. | 1.98B | 2.36% | 1,557,076 | 1.93B |
| 268 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.98B | 2.01% | 3,562,178 | -665.00K |
| 269 | VRDN | Viridian Therapeutics, Inc. | 1.98B | 2.93% | 5,787,325 | 70.92M |
| 270 | PLSE | Pulse Biosciences, Inc. | 1.97B | 3.42% | 1,813,743 | 751.00K |
| 271 | NUVB | Nuvation Bio Inc. | 1.97B | -2.75% | 35,238,277 | 143.05M |
| 272 | ATAI | AtaiBeckley Inc. | 1.95B | 15.50% | 63,236,993 | 3.49M |
| 273 | GHRS | GH Research PLC | 1.94B | 11.37% | 275,642 | - |
| 274 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 2.22% | 130,070 | 1.20B |
| 275 | RAPP | Rapport Therapeutics, Inc. | 1.92B | 2.96% | 1,618,978 | 20.00M |
| 276 | SION | Sionna Therapeutics, Inc. | 1.90B | -1.38% | 1,019,148 | - |
| 277 | IOVA | Iovance Biotherapeutics, Inc. | 1.90B | 0.95% | 23,715,866 | 285.61M |
| 278 | TYRA | Tyra Biosciences, Inc. | 1.90B | 3.04% | 4,230,021 | - |
| 279 | SNDX | Syndax Pharmaceuticals, Inc. | 1.89B | 7.57% | 4,567,219 | 217.17M |
| 280 | AVAH | Aveanna Healthcare Holdings Inc. | 1.89B | 2.12% | 6,439,801 | 2.52B |
| 281 | GLUE | Monte Rosa Therapeutics, Inc. | 1.88B | 2.91% | 5,919,915 | 42.95M |
| 282 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | 5.39% | 42,587,971 | 66.41M |
| 283 | ALMR | Alamar Biosciences, Inc. | 1.85B | -0.74% | 2,143,522 | 87.16M |
| 284 | NEO | NeoGenomics, Inc. | 1.85B | 3.20% | 7,125,319 | 745.97M |
| 285 | ABSI | Absci Corporation | 1.84B | 6.66% | 13,453,390 | 1.84M |
| 286 | ANAB | AnaptysBio, Inc. | 1.84B | 5.81% | 1,361,133 | 232.39M |
| 287 | OMCL | Omnicell, Inc. | 1.83B | 1.52% | 2,563,064 | 1.23B |
| 288 | SNDA | Sonida Senior Living, Inc. | 1.82B | -0.64% | 3,873,115 | 367.34M |
| 289 | HCM | HUTCHMED (China) Limited | 1.82B | -1.17% | 48,374 | 548.51M |
| 290 | NBTX | Nanobiotix S.A. | 1.80B | 4.53% | 111,962 | 38.27M |
| 291 | ANIP | ANI Pharmaceuticals, Inc. | 1.79B | 1.46% | 780,607 | 923.71M |
| 292 | NVCR | NovoCure Limited | 1.79B | 2.52% | 3,294,091 | 674.41M |
| 293 | SRPT | Sarepta Therapeutics, Inc. | 1.78B | 5.18% | 20,026,919 | 2.18B |
| 294 | BHC | Bausch Health Companies Inc. | 1.78B | -9.85% | 12,661,386 | 10.53B |
| 295 | ADUS | Addus HomeCare Corporation | 1.77B | 0.09% | 813,763 | 1.45B |
| 296 | BCAX | Bicara Therapeutics Inc. | 1.77B | 2.01% | 4,601,411 | - |
| 297 | ZYME | Zymeworks Inc. | 1.76B | 1.60% | 942,298 | 81.26M |
| 298 | INVA | Innoviva, Inc. | 1.74B | 0.94% | 2,834,672 | 420.69M |
| 299 | TRLV | Trulieve Cannabis Corp. | 1.73B | 5.52% | 1,608,534 | 1.17B |
| 300 | VIR | Vir Biotechnology, Inc. | 1.69B | 1.52% | 7,498,725 | 65.50M |
| 301 | MESO | Mesoblast Limited | 1.69B | -9.03% | 421,696 | 65.38M |
| 302 | SEPN | Septerna, Inc. | 1.68B | 8.11% | 1,480,133 | 72.26M |
| 303 | URGN | UroGen Pharma Ltd. | 1.68B | 0.47% | 1,348,411 | 140.49M |
| 304 | FTRE | Fortrea Holdings Inc. | 1.67B | -0.34% | 3,629,668 | 2.71B |
| 305 | HCSG | Healthcare Services Group, Inc. | 1.67B | 2.88% | 2,346,374 | 1.85B |
| 306 | MLTX | MoonLake Immunotherapeutics | 1.64B | -0.45% | 1,678,523 | - |
| 307 | ZBIO | Zenas BioPharma, Inc. | 1.63B | 4.86% | 3,500,481 | 10.00M |
| 308 | AKTS | Aktis Oncology, Inc. | 1.63B | -5.49% | 1,230,701 | 8.28M |
| 309 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.61B | 1.63% | 6,471,242 | 204.73M |
| 310 | AVBP | ArriVent BioPharma, Inc. | 1.58B | 0.50% | 1,956,585 | - |
| 311 | MAZE | Maze Therapeutics, Inc. | 1.57B | 5.22% | 3,545,147 | 20.00M |
| 312 | IMCR | Immunocore Holdings plc | 1.57B | 1.11% | 509,947 | 412.81M |
| 313 | HROW | Harrow, Inc. | 1.57B | 1.37% | 1,524,208 | 268.68M |
| 314 | DMRA | Damora Therapeutics, Inc. | 1.56B | 12.36% | 8,623,777 | - |
| 315 | KMTS | Kestra Medical Technologies, Ltd. | 1.54B | 17.05% | 1,573,711 | 83.72M |
| 316 | CAPR | Capricor Therapeutics, Inc. | 1.53B | -13.03% | 5,489,478 | 11.13M |
| 317 | ATRC | AtriCure, Inc. | 1.53B | 7.29% | 2,774,872 | 552.16M |
| 318 | TDOC | Teladoc Health, Inc. | 1.51B | 6.07% | 9,043,957 | 2.51B |
| 319 | COAG | Hemab Therapeutics Holdings, Inc. | 1.51B | 16.77% | 329,199 | - |
| 320 | MPLT | MapLight Therapeutics, Inc. | 1.51B | 4.13% | 1,708,666 | - |
| 321 | SVRA | Savara Inc. | 1.50B | -2.16% | 6,158,836 | - |
| 322 | CDNA | CareDx, Inc. | 1.49B | 3.48% | 1,646,951 | 412.82M |
| 323 | INNV | InnovAge Holding Corp. | 1.46B | 4.25% | 1,324,838 | 949.17M |
| 324 | NVAX | Novavax, Inc. | 1.46B | 3.74% | 8,409,599 | 596.34M |
| 325 | IART | Integra LifeSciences Holdings Corporation | 1.46B | 3.65% | 2,157,462 | 1.64B |
| 326 | STAA | STAAR Surgical Company | 1.46B | -6.15% | 1,175,225 | 290.38M |
| 327 | AAPG | Ascentage Pharma Group International | 1.43B | -1.64% | 195,418 | 82.08M |
| 328 | ATEC | Alphatec Holdings, Inc. | 1.43B | 5.32% | 6,166,793 | 787.08M |
| 329 | BLFS | BioLife Solutions, Inc. | 1.40B | 4.25% | 4,000,042 | 101.66M |
| 330 | ARDT | Ardent Health, Inc. | 1.39B | 3.95% | 1,008,727 | 6.43B |
| 331 | INBX | Inhibrx Biosciences, Inc. | 1.39B | -0.52% | 619,792 | 1.30M |
| 332 | PRGO | Perrigo Company plc | 1.38B | 2.79% | 22,384,204 | 4.18B |
| 333 | ARDX | Ardelyx, Inc. | 1.37B | -8.42% | 17,524,272 | 427.68M |
| 334 | AHCO | AdaptHealth Corp. | 1.37B | 2.69% | 4,334,830 | 3.29B |
| 335 | PSNL | Personalis, Inc. | 1.36B | 3.42% | 8,354,793 | 64.52M |
| 336 | AVLN | Avalyn Pharma Inc. | 1.36B | 5.97% | 2,402,479 | - |
| 337 | XERS | Xeris Biopharma Holdings, Inc. | 1.33B | 3.92% | 6,342,473 | 314.85M |
| 338 | INSP | Inspire Medical Systems, Inc. | 1.32B | 5.22% | 5,101,055 | 915.25M |
| 339 | ENOV | Enovis Corporation | 1.31B | 3.18% | 1,929,549 | 2.28B |
| 340 | JBIO | Jade Biosciences, Inc. | 1.31B | 0.87% | 2,664,341 | - |
| 341 | AHG | Akso Health Group | 1.30B | 13.43% | 57,849 | 14.84M |
| 342 | IMTX | Immatics N.V. | 1.30B | -0.10% | 228,261 | 43.00M |
| 343 | PAHC | Phibro Animal Health Corporation | 1.29B | -0.44% | 537,204 | 1.50B |
| 344 | PRCT | PROCEPT BioRobotics Corporation | 1.28B | 4.98% | 2,650,083 | 322.02M |
| 345 | MNKD | MannKind Corporation | 1.28B | 5.34% | 11,868,006 | 360.78M |
| 346 | AMN | AMN Healthcare Services, Inc. | 1.27B | 1.33% | 1,974,976 | 3.42B |
| 347 | SDGR | Schrödinger, Inc. | 1.26B | 4.46% | 3,928,660 | 254.91M |
| 348 | PNTG | The Pennant Group, Inc. | 1.25B | 0.17% | 1,034,828 | 1.02B |
| 349 | ALVO | Alvotech | 1.24B | 5.75% | 991,866 | 562.04M |
| 350 | OMDA | Omada Health, Inc. | 1.24B | 10.53% | 3,310,815 | 283.30M |
| 351 | IRMD | IRADIMED CORPORATION | 1.20B | 0.10% | 322,741 | 86.28M |
| 352 | COLL | Collegium Pharmaceutical, Inc. | 1.19B | 5.02% | 1,618,507 | 796.33M |
| 353 | AZTA | Azenta, Inc. | 1.18B | 3.53% | 1,719,627 | 596.48M |
| 354 | AVNS | Avanos Medical, Inc. | 1.17B | 0.20% | 1,597,038 | 715.90M |
| 355 | LMRI | Lumexa Imaging Holdings, Inc. | 1.16B | 14.37% | 2,106,126 | 1.03B |
| 356 | OPK | OPKO Health, Inc. | 1.16B | 1.32% | 8,415,323 | 581.12M |
| 357 | AORT | Artivion, Inc. | 1.15B | 4.19% | 2,614,166 | 458.69M |
| 358 | SPTX | Seaport Therapeutics, Inc. | 1.15B | 10.54% | 194,415 | - |
| 359 | EYPT | EyePoint, Inc. | 1.15B | -0.36% | 3,554,606 | 7.61M |
| 360 | NUTX | Nutex Health Inc. | 1.15B | 11.60% | 247,310 | 879.95M |
| 361 | CRVS | Corvus Pharmaceuticals, Inc. | 1.13B | 3.37% | 3,430,305 | - |
| 362 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.13B | 11.35% | 39,463,853 | 69.64M |
| 363 | CGEM | Cullinan Therapeutics, Inc. | 1.13B | -0.43% | 2,725,251 | - |
| 364 | WVE | Wave Life Sciences Ltd. | 1.12B | 1.39% | 6,686,691 | 71.80M |
| 365 | MGTX | MeiraGTx Holdings plc | 1.12B | 5.03% | 4,775,428 | 79.76M |
| 366 | XNCR | Xencor, Inc. | 1.12B | 2.10% | 1,981,662 | 97.36M |
| 367 | TNDM | Tandem Diabetes Care, Inc. | 1.11B | 3.05% | 3,369,115 | 1.03B |
| 368 | CNMD | CONMED Corporation | 1.08B | 4.02% | 843,844 | 1.37B |
| 369 | BIOA | BioAge Labs, Inc. | 1.06B | 5.04% | 3,119,826 | 10.32M |
| 370 | CRON | Cronos Group Inc. | 1.05B | 2.93% | 1,328,384 | 159.54M |
| 371 | USPH | U.S. Physical Therapy, Inc. | 1.05B | 3.71% | 377,714 | 787.69M |
| 372 | SANA | Sana Biotechnology, Inc. | 1.03B | 4.91% | 10,365,342 | - |
| 373 | OLMA | Olema Pharmaceuticals, Inc. | 994.89M | -0.35% | 5,541,136 | - |
| 374 | EVO | Evotec SE | 994.57M | 1.11% | 17,287 | 859.03M |
| 375 | PCRX | Pacira BioSciences, Inc. | 993.14M | 3.57% | 1,022,650 | 734.86M |
| 376 | ORIC | ORIC Pharmaceuticals, Inc. | 986.52M | 0.74% | 3,762,525 | - |
| 377 | DRTS | Alpha Tau Medical Ltd. | 981.12M | -2.60% | 491,714 | - |
| 378 | ETON | Eton Pharmaceuticals, Inc. | 977.91M | 2.53% | 1,003,515 | 86.93M |
| 379 | DBVT | DBV Technologies S.A. | 969.96M | -0.06% | 208,757 | 5.74M |
| 380 | KURA | Kura Oncology, Inc. | 967.64M | 5.21% | 5,273,189 | 71.64M |
| 381 | AMPH | Amphastar Pharmaceuticals, Inc. | 960.34M | 3.52% | 623,978 | 720.53M |
| 382 | REPL | Replimune Group, Inc. | 960.32M | 4.49% | 9,985,314 | - |
| 383 | AVTX | Avalo Therapeutics, Inc. | 956.69M | 1.11% | 8,576,599 | 59.00K |
| 384 | ANRO | Alto Neuroscience, Inc. | 948.94M | 6.88% | 4,414,919 | - |
| 385 | GDRX | GoodRx Holdings, Inc. | 948.29M | 4.09% | 1,075,241 | 787.89M |
| 386 | AVR | Anteris Technologies Global Corp. | 943.25M | -1.92% | 4,667,218 | 1.85M |
| 387 | QDEL | QuidelOrtho Corporation | 940.35M | 2.00% | 3,507,578 | 2.66B |
| 388 | PHAR | Pharming Group N.V. | 939.20M | 0.53% | 3,484 | 369.49M |
| 389 | INMD | InMode Ltd. | 926.94M | -1.22% | 1,141,040 | 374.64M |
| 390 | LBRX | LB Pharmaceuticals Inc | 915.36M | 2.97% | 1,413,712 | - |
| 391 | SLDB | Solid Biosciences Inc. | 914.60M | 4.85% | 6,302,037 | - |
| 392 | JANX | Janux Therapeutics, Inc. | 911.11M | 2.47% | 3,702,025 | 13.73M |
| 393 | TBPH | Theravance Biopharma, Inc. | 908.88M | 1.38% | 1,311,425 | 109.78M |
| 394 | CERT | Certara, Inc. | 908.50M | 6.38% | 17,571,436 | 419.75M |
| 395 | EVMN | Evommune, Inc. | 906.94M | 4.35% | 1,402,427 | 10.00M |
| 396 | ABUS | Arbutus Biopharma Corporation | 904.72M | 3.85% | 6,802,442 | 191.45M |
| 397 | ANNX | Annexon, Inc. | 897.86M | 6.41% | 14,807,062 | - |
| 398 | TALK | Talkspace, Inc. | 874.42M | 0.58% | 5,877,607 | 238.37M |
| 399 | VOR | Vor Biopharma Inc. | 872.39M | 7.84% | 8,126,292 | - |
| 400 | ODTX | Odyssey Therapeutics, Inc. | 864.68M | 1.46% | 252,772 | 1.06M |
| 401 | PHAT | Phathom Pharmaceuticals, Inc. | 851.49M | 3.68% | 2,661,554 | 204.89M |
| 402 | SPRY | ARS Pharmaceuticals, Inc. | 848.05M | 6.48% | 5,015,475 | 98.99M |
| 403 | GERN | Geron Corporation | 846.81M | -3.65% | 36,634,117 | 196.12M |
| 404 | DSGN | Design Therapeutics, Inc. | 833.80M | -0.67% | 2,909,250 | - |
| 405 | BVS | Bioventus Inc. | 816.97M | 0.51% | 1,435,044 | 576.30M |
| 406 | ESPR | Esperion Therapeutics, Inc. | 816.06M | 0.63% | 13,995,110 | 418.24M |
| 407 | ZVRA | Zevra Therapeutics, Inc. | 799.24M | 2.19% | 2,878,207 | 122.29M |
| 408 | GMRS | GMR Solutions Inc. | 784.79M | -0.82% | 753,545 | 5.83B |
| 409 | HSTM | HealthStream, Inc. | 780.92M | 4.01% | 681,763 | 311.78M |
| 410 | AURA | Aura Biosciences, Inc. | 772.10M | 2.04% | 1,628,001 | - |
| 411 | IVA | Inventiva S.A. | 772.09M | -2.57% | 1,335,151 | 7.94M |
| 412 | SIBN | SI-BONE, Inc. | 768.57M | 3.40% | 1,718,162 | 206.22M |
| 413 | CBLL | CeriBell, Inc. | 758.10M | 1.27% | 1,195,631 | 95.07M |
| 414 | BBNX | Beta Bionics, Inc. | 749.53M | 5.72% | 2,041,708 | 110.24M |
| 415 | CLYM | Climb Bio, Inc. | 748.97M | 3.32% | 6,319,983 | - |
| 416 | CTMX | CytomX Therapeutics, Inc. | 740.19M | 3.98% | 28,894,577 | 35.54M |
| 417 | CSTL | Castle Biosciences, Inc. | 737.02M | 6.07% | 1,043,847 | 339.92M |
| 418 | ALLO | Allogene Therapeutics, Inc. | 735.18M | 3.40% | 25,919,247 | 22.00K |
| 419 | OCS | Oculis Holding AG | 724.66M | 2.21% | 374,879 | 1.40M |
| 420 | NVCT | Nuvectis Pharma, Inc. | 721.23M | -2.44% | 1,277,737 | - |
| 421 | CADL | Candel Therapeutics, Inc. | 717.32M | 3.38% | 4,925,639 | - |
| 422 | RIGL | Rigel Pharmaceuticals, Inc. | 715.85M | 4.60% | 885,245 | 299.77M |
| 423 | IMMX | Immix Biopharma, Inc. | 710.48M | 2.67% | 7,137,070 | - |
| 424 | SGP | SpyGlass Pharma, Inc. | 708.12M | 12.60% | 1,478,781 | - |
| 425 | RLMD | Relmada Therapeutics, Inc. | 701.72M | 3.72% | 15,605,264 | - |
| 426 | ACRS | Aclaris Therapeutics, Inc. | 698.32M | 1.83% | 8,838,855 | 8.37M |
| 427 | TENX | Tenax Therapeutics, Inc. | 686.67M | 4.27% | 5,207,905 | - |
| 428 | TCMD | Tactile Systems Technology, Inc. | 683.00M | 8.14% | 1,284,805 | 343.52M |
| 429 | AGMB | AgomAb Therapeutics NV | 680.11M | 2.83% | 96,414 | - |
| 430 | IRWD | Ironwood Pharmaceuticals, Inc. | 679.85M | 7.55% | 7,108,527 | 361.51M |
| 431 | DNA | Ginkgo Bioworks Holdings, Inc. | 669.58M | 7.11% | 2,529,225 | 151.40M |
| 432 | SSII | SS Innovations International, Inc. | 668.44M | -7.73% | 57,974 | 48.47M |
| 433 | NNNN | Anbio Biotechnology | 637.74M | -9.75% | 65,549 | 8.65M |
| 434 | OMER | Omeros Corporation | 627.49M | -19.12% | 10,918,913 | 9.89M |
| 435 | PHR | Phreesia, Inc. | 622.45M | 10.30% | 2,996,872 | 495.59M |
| 436 | EIKN | Eikon Therapeutics, Inc. | 619.89M | 16.24% | 3,172,878 | - |
| 437 | EVH | Evolent Health, Inc. | 619.77M | 9.54% | 6,230,367 | 1.89B |
| 438 | DRUG | Bright Minds Biosciences Inc. | 619.56M | 3.38% | 365,180 | - |
| 439 | PRME | Prime Medicine, Inc. | 619.52M | 7.86% | 7,659,139 | 4.03M |
| 440 | ACHV | Achieve Life Sciences, Inc. | 618.01M | 5.61% | 12,441,224 | - |
| 441 | CBIO | Crescent Biopharma, Inc. | 616.73M | 9.24% | 3,051,990 | 11.88M |
| 442 | CRMD | CorMedix Inc. | 615.85M | 1.68% | 4,576,864 | 400.05M |
| 443 | FDMT | 4D Molecular Therapeutics, Inc. | 606.40M | 0.69% | 2,021,428 | 88.24M |
| 444 | SLBT | SL Science Holding Limited | 606.09M | -10.50% | 115,025 | - |
| 445 | TECX | Tectonic Therapeutic, Inc. | 603.63M | 3.09% | 307,183 | - |
| 446 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 592.79M | -3.77% | 715,986 | - |
| 447 | FTH | Faeth Therapeutics, Inc. | 589.56M | -7.30% | 145,921 | - |
| 448 | MNPR | Monopar Therapeutics Inc. | 587.35M | 0.06% | 310,269 | - |
| 449 | MDXG | MiMedx Group, Inc. | 585.36M | 3.15% | 5,633,371 | 389.42M |
| 450 | CERS | Cerus Corporation | 585.08M | 2.10% | 7,434,823 | 216.56M |
| 451 | CTKB | Cytek Biosciences, Inc. | 578.56M | 0.22% | 3,416,628 | 204.17M |
| 452 | BWAY | BrainsWay Ltd. | 576.12M | -0.41% | 69,344 | 56.22M |
| 453 | GYRE | Gyre Therapeutics, Inc. | 574.73M | 0.96% | 854,113 | 117.05M |
| 454 | FLGT | Fulgent Genetics, Inc. | 566.88M | 2.67% | 505,913 | 320.35M |
| 455 | CTEV | Claritev Corporation | 565.13M | -4.52% | 460,263 | 978.76M |
| 456 | NPCE | NeuroPace, Inc. | 561.52M | 0.67% | 782,195 | 99.53M |
| 457 | TRAX | First Tracks Biotherapeutics, Inc. | 559.32M | -2.08% | 1,731,942 | - |
| 458 | ANGO | AngioDynamics, Inc. | 558.54M | -1.90% | 959,400 | 313.73M |
| 459 | MYGN | Myriad Genetics, Inc. | 555.36M | 8.29% | 5,205,835 | 829.00M |
| 460 | CLPT | ClearPoint Neuro, Inc. | 554.21M | 2.90% | 1,493,844 | 40.61M |
| 461 | TLRY | Tilray Brands, Inc. | 553.47M | 4.04% | 3,237,709 | 858.28M |
| 462 | PROK | ProKidney Corp. | 552.77M | 7.65% | 9,463,457 | 889.00K |
| 463 | AQST | Aquestive Therapeutics, Inc. | 550.73M | -1.68% | 7,384,748 | 50.27M |
| 464 | ALT | Altimmune, Inc. | 548.42M | -1.74% | 17,105,424 | 36.00K |
| 465 | RGNX | REGENXBIO Inc. | 541.79M | 2.34% | 4,356,522 | 87.82M |
| 466 | TOI | The Oncology Institute, Inc. | 538.91M | 5.27% | 5,202,826 | 545.76M |
| 467 | CTNM | Contineum Therapeutics, Inc. | 530.51M | 6.21% | 3,888,537 | - |
| 468 | ASMB | Assembly Biosciences, Inc. | 529.91M | 10.22% | 1,589,358 | 71.10M |
| 469 | XOMA | XOMA Royalty Corporation | 528.60M | -0.12% | 439,306 | 48.56M |
| 470 | RZLT | Rezolute, Inc. | 526.51M | 0.20% | 6,577,310 | - |
| 471 | PRTA | Prothena Corporation plc | 524.58M | 8.09% | 1,914,377 | 57.94M |
| 472 | KIDS | OrthoPediatrics Corp. | 521.41M | 3.47% | 542,417 | 243.30M |
| 473 | ARVN | Arvinas, Inc. | 516.17M | -0.37% | 3,028,565 | 89.40M |
| 474 | FBRX | Forte Biosciences, Inc. | 513.88M | 12.40% | 3,079,361 | - |
| 475 | KYTX | Kyverna Therapeutics, Inc. | 513.11M | 2.93% | 6,756,673 | - |
| 476 | PACB | Pacific Biosciences of California, Inc. | 512.49M | 3.12% | 19,180,263 | 160.03M |
| 477 | ZURA | Zura Bio Limited | 508.24M | 17.84% | 9,625,491 | - |
| 478 | OCGN | Ocugen, Inc. | 507.78M | 9.49% | 57,047,122 | 4.47M |
| 479 | NGNE | Neurogene Inc. | 506.13M | 5.33% | 504,970 | 925.00K |
| 480 | STRO | Sutro Biopharma, Inc. | 505.73M | 3.28% | 2,773,529 | 99.61M |
| 481 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 5.42M |
| 482 | CABA | Cabaletta Bio, Inc. | 495.69M | 4.11% | 24,303,072 | - |
| 483 | STTK | Shattuck Labs, Inc. | 493.82M | 8.97% | 12,486,828 | 1.00M |
| 484 | MOBI | Mobia Medical, Inc. | 486.43M | 12.45% | 138,418 | 38.45M |
| 485 | VALN | Valneva SE | 482.77M | -0.38% | 27,494 | 180.25M |
| 486 | SOPH | SOPHiA GENETICS SA | 482.40M | 1.05% | 423,930 | 81.18M |
| 487 | SLN | Silence Therapeutics plc | 478.95M | 1.40% | 1,080,895 | 839.00K |
| 488 | OVID | Ovid Therapeutics Inc. | 475.93M | 5.37% | 22,546,134 | 7.12M |
| 489 | SI | Shoulder Innovations, Inc. | 472.62M | 5.46% | 766,969 | 53.89M |
| 490 | WEAV | Weave Communications, Inc. | 471.03M | 8.62% | 2,055,271 | 248.72M |
| 491 | CCCC | C4 Therapeutics, Inc. | 471.02M | -3.18% | 20,144,416 | 34.86M |
| 492 | EOLS | Evolus, Inc. | 469.54M | -0.28% | 2,075,327 | 301.79M |
| 493 | NRC | NRC Health | 468.99M | 2.11% | 235,465 | 138.64M |
| 494 | ARTV | Artiva Biotherapeutics, Inc. | 467.42M | 8.95% | 1,040,481 | 251.00K |
| 495 | SRTA | Strata Critical Medical, Inc. | 458.59M | -1.12% | 2,079,929 | 228.58M |
| 496 | DCTH | Delcath Systems, Inc. | 446.71M | 5.03% | 1,410,401 | 90.44M |
| 497 | VMD | Viemed Healthcare, Inc. | 445.86M | -0.51% | 882,599 | 286.57M |
| 498 | CYH | Community Health Systems, Inc. | 444.29M | 2.50% | 5,168,897 | 12.29B |
| 499 | EBS | Emergent BioSolutions Inc. | 440.12M | 6.89% | 2,119,447 | 676.80M |
| 500 | EDIT | Editas Medicine, Inc. | 437.37M | 4.01% | 6,394,393 | 38.69M |